Shin Nippon Biomedical Laboratories, Ltd. 2395

TSE · Japan · Commercial Services

¥1,293.00-30.00 (-2.27%)

Market closed· Oct 2, 2026, 6:30 AM UTC· JPY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Shin Nippon Biomedical Laboratories, Ltd. 2395

TSE · Japan · Commercial Services

¥1,293.00-30.00 (-2.27%)

Market closed· Oct 2, 2026, 6:30 AM UTC· JPY · Data may be delayed

Company news

Yahoo FinanceJun 04, 2026

Satsuma Pharmaceuticals Announces Presentation of Two Clinical Program Abstracts at the American Headache Society's 68th Annual Scientific Meeting

Satsuma Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing innovative treatments for people living with migraine, today announced that two abstracts highlighting findings from its clinical development program have been selected for presentation at the American Headache Society's (AHS) 68th Annual Scientific Meeting. The meeting will take place June 4 - 7, 2026, at the Orlando World Center Marriott in Orlando, Florida, with both in-person and virtual attendance options availa

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.